AngioDynamics, Inc. (ANGO): Price and Financial Metrics

AngioDynamics, Inc. (ANGO): $23.58

-0.65 (-2.68%)

POWR Rating

Component Grades














  • ANGO scores best on the Growth dimension, with a Growth rank ahead of 93.17% of US stocks.
  • ANGO's strongest trending metric is Growth; it's been moving up over the last 48 weeks.
  • ANGO's current lowest rank is in the Quality metric (where it is better than 22.36% of US stocks).

ANGO Stock Summary

  • The price/operating cash flow metric for Angiodynamics Inc is higher than 87.21% of stocks in our set with a positive cash flow.
  • For ANGO, its debt to operating expenses ratio is greater than that reported by just 13.79% of US equities we're observing.
  • With a year-over-year growth in debt of -50%, Angiodynamics Inc's debt growth rate surpasses just 9.38% of about US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Angiodynamics Inc are KVHI, QGEN, MIND, JAMF, and CARS.
  • ANGO's SEC filings can be seen here. And to visit Angiodynamics Inc's official web site, go to

ANGO Valuation Summary

  • ANGO's EV/EBIT ratio is -30.1; this is 202.73% lower than that of the median Healthcare stock.
  • Over the past 210 months, ANGO's price/earnings ratio has gone down 105.7.
  • Over the past 210 months, ANGO's EV/EBIT ratio has gone down 69.7.

Below are key valuation metrics over time for ANGO.

Stock Date P/S P/B P/E EV/EBIT
ANGO 2021-08-31 3.7 2.5 -34.5 -30.1
ANGO 2021-08-30 3.8 2.5 -34.7 -30.3
ANGO 2021-08-27 3.7 2.5 -34.4 -30.0
ANGO 2021-08-26 3.6 2.4 -33.6 -29.3
ANGO 2021-08-25 3.7 2.4 -33.7 -29.4
ANGO 2021-08-24 3.7 2.4 -34.0 -29.7

ANGO Growth Metrics

  • The 2 year price growth rate now stands at -47.74%.
  • Its 3 year price growth rate is now at 129.04%.
  • Its 4 year cash and equivalents growth rate is now at 24.04%.
ANGO's revenue has moved down $65,288,000 over the prior 52 months.

The table below shows ANGO's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 291.01 24.093 -31.548
2021-03-31 272.5 15.774 -169.147
2020-12-31 271.098 -7.934 -171.312
2020-09-30 268.331 -13.445 -169.78
2020-06-30 264.157 -14.554 -166.787
2020-03-31 213.275 6.578 49.153

ANGO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ANGO has a Quality Grade of D, ranking ahead of 23.52% of graded US stocks.
  • ANGO's asset turnover comes in at 0.503 -- ranking 93rd of 183 Medical Equipment stocks.
  • EW, ATRS, and IVC are the stocks whose asset turnover ratios are most correlated with ANGO.

The table below shows ANGO's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-05-31 0.503 0.539 -0.282
2021-02-28 0.464 0.531 -1.297
2020-11-30 0.434 0.540 -1.344
2020-08-31 0.407 0.551 -1.516
2020-05-31 0.385 0.569 -1.758
2020-02-29 0.286 0.637 0.427

ANGO Price Target

For more insight on analysts targets of ANGO, see our ANGO price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $30.00 Average Broker Recommendation 1.75 (Moderate Buy)

ANGO Stock Price Chart Interactive Chart >

Price chart for ANGO

ANGO Price/Volume Stats

Current price $23.58 52-week high $30.25
Prev. close $24.23 52-week low $10.17
Day low $23.52 Volume 69,189
Day high $24.37 Avg. volume 272,152
50-day MA $26.78 Dividend yield N/A
200-day MA $23.18 Market Cap 911.37M

AngioDynamics, Inc. (ANGO) Company Bio

AngioDynamics designs, manufactures, and sells various medical, surgical, and diagnostic devices for vascular access, surgery, peripheral vascular disease, and oncology in the United States and internationally. The company was founded in 1988 and is based in Latham, New York.

ANGO Latest News Stream

Event/Time News Detail
Loading, please wait...

ANGO Latest Social Stream

Loading social stream, please wait...

View Full ANGO Social Stream

Latest ANGO News From Around the Web

Below are the latest news stories about Angiodynamics Inc that investors may wish to consider to help them evaluate ANGO as an investment opportunity.

Tumor Embolization Market Growth Prospects, Key Vendors, Future Scenario Forecast to 2028 | Penumbra, Inc, Depuy Synthes, Cook, Balt Extrusion, Angiodynamics

Tumor Embolization Market study by The Insight Partners provides details about the market dynamics affecting the market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive landscape and trends prevailing over the years.

OpenPR | September 16, 2021

AngioDynamics to Report Fiscal 2022 First Quarter Financial Results on September 30, 2021

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular dise

Business Wire | September 15, 2021

Transradial Access Market Analysis and Forecast 2028 By Keyplayers Stryker, CARDINAL HEALTH, Angiodynamics Inc., BD, Terumo Corporation, Teleflex Incorporated, Smiths Group plc, MEDTRONIC, Boston Scientific Corporation, Edwards Lifesciences Corporation

Transradial access market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 2,413.79 million by 2027 growing at a CAGR of 8.80% in the

OpenPR | September 10, 2021

Cryoablation Devices Market to Witness Growth Acceleration by Top Key Players Like Smith & Nephew, Olympus, St. Jude, Boston, Conmed, Galil Medical, Atricure, Angiodynamics

Cryoablation Devices Market poised to witness significant growth owing to its ability to treat various diseased conditions in humans and animals. Availability of different products with customized probes for cryoablation will help boost this market over the forecast period. Other

OpenPR | September 10, 2021

Varicose Vein Treatment Devices Market By Treatment Type, Device, End User, and Geography Forecast till 2027 | Biolitec, AngioDynamics, Quanta System SpA, Lumenis, WONTECH, INTERmedic Technology

Varicose veins can be aesthetically displeasing. They become problematic only in case they cause pain, aching, swelling, and considerable discomfort. In severe cases, they may rupture and can lead to ulcers. Available options for the treatment of this condition have

OpenPR | September 9, 2021

Read More 'ANGO' Stories Here

ANGO Price Returns

1-mo -16.44%
3-mo -13.09%
6-mo 1.86%
1-year 120.99%
3-year 8.46%
5-year 38.62%
YTD 53.82%
2020 -4.25%
2019 -20.47%
2018 21.05%
2017 -1.42%
2016 38.96%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 1.6024 seconds.